Contribution of biochemistry in the diagnosis of the nervous stage of human African trypanosomiasis.

被引:0
|
作者
Bisser, S [1 ]
Bouteille, B [1 ]
Sarda, J [1 ]
Stanghellini, A [1 ]
Ricard, D [1 ]
Jauberteau, MO [1 ]
Marchan, F [1 ]
Dumas, M [1 ]
Breton, JC [1 ]
机构
[1] Fac Med Limoges, Inst Epidemiol Neurol & Neurol Trop, F-87025 Limoges, France
来源
关键词
human African trypanosomiasis; biochemistry; diagnosis of the nervous stage; Congo;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The stage of human African trypanosomiasis (HAT) is important to define precisely as far as it is directly related to the type of treatment used. The beginning of the neurological involvement is difficult to find out because there is no known specific clinical or biological sign. This study is trying to look for a precise marker and has been realized in Congo. 70 subjects with parasitologically confirmed HAT and 70 controls are included. The stage of HAT is determined according to the classical definition on the field using the cerebrospinal fluid (CSF) cell count: less than 5 cells/mu l for he first stage (PI), more than 5 cells/mu l for the second stage (P2). The blood analysis has included : glucose, urea, creatinine, sodium, potassium, calcium, chloride, phosphorus, uric acid, total bilirubin, unconjugated bilirubin, total cholesterol, triglycerides, total proteins, aspartate aminotransferase, alanine aminotransferase, creatinine phosphokinase, alkaline phosphatase, gamma-glutamyltransferase, immunoglobulins M and G, C3c fraction of complement, transferrin, seromucoid alpha 1, haptoglobin and albumin. In CSF we have analyzed IgM, IgG, protein levels and the bloodbrain barrier (BBB) impairment. The comparison between the subjects and heir controls he subjects in P1 and in P2, the CSF cell count and the other CSF alterations show the interest of the IgM level in CSF and the BBB impairment to identify subjects in P2. However there is a low gradation in the biological disturbances and not a precise threshold point Nevertheless it seems reasonable to raise the CSF cell count level to 20 cells/mu l to define the beginning of the nervous involvement.
引用
收藏
页码:321 / 326
页数:6
相关论文
共 50 条
  • [1] Contribution of biochemistry in the diagnosis of the nervous stage of human African trypanosomiasis. Commentary
    Bourgeade, M
    BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE, 1997, 90 (05): : 326 - 326
  • [2] Experimental models of human African trypanosomiasis.
    Bouteille, B
    Millet, P
    Enanga, B
    Ndong, JMM
    Keita, M
    Jauberteau, MO
    Georges, A
    Dumas, M
    BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE, 1998, 91 (02): : 127 - 132
  • [3] African human trypanosomiasis. Therapeutic strategies.
    Stanghellini, A
    BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE, 2000, 93 (01): : 31 - 33
  • [4] Carbohydrate metabolism in human trypanosomiasis.
    Wormall, A
    BIOCHEMICAL JOURNAL, 1932, 26 : 1777 - 1787
  • [5] Human activities and American trypanosomiasis. A review
    Walter, A
    PARASITE, 2003, 10 (03) : 191 - 204
  • [6] DIAGNOSIS OF HUMAN AFRICAN TRYPANOSOMIASIS
    VANMEIRVENNE, N
    ANNALES DE LA SOCIETE BELGE DE MEDECINE TROPICALE, 1992, 72 : 53 - 56
  • [7] Note on the use of chrysoidin in human trypanosomiasis.
    Neave, S
    LANCET, 1905, 1 : 1645 - 1646
  • [8] AFRICAN HUMAN TRYPANOSOMIASIS - IMMUNOENZYMOLOGICAL DIAGNOSIS
    CAILLIEZ, M
    POUPIN, F
    SAVEL, J
    NOUVELLE PRESSE MEDICALE, 1979, 8 (07): : 522 - 523
  • [9] IMMUNOLOGICAL DIAGNOSIS OF HUMAN AFRICAN TRYPANOSOMIASIS
    SAVEL, J
    COULAUD, JP
    MEDECINE ET MALADIES INFECTIEUSES, 1979, 9 (05): : 293 - 295
  • [10] Validity, cost and feasibility of the mAECT and CTC as the tests of confirmation in the detection of the African Human Trypanosomiasis.
    Lutumba, P
    Robays, J
    Miaka, C
    Kande, V
    Mumba, D
    Büscher, P
    Dujardin, B
    Boelaert, M
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2006, 11 (04) : 470 - 478